Medbio, LLC (“Medbio”), a contract manufacturer specializing in clean room injection molding of plastic components for the medical and biotechnology industries, has acquired Polymer Conversions, Inc. (“PCI”).

Together these businesses create a premier medical device manufacturing company, capable of supporting the rapid growth of the company’s customers. Medbio is a portfolio company of Graham Partners, a private investment firm targeting industrial technology and advanced manufacturing companies.

Medbio is a contract manufacturer offering innovative manufacturing solutions for the medical and biotechnology industries.

Headquartered in Western New York, Polymer Conversions is a full-service medical device contract manufacturer that specializes in complex thermoplastic injection molding and value-add assembly.

PCI is highly complementary to the existing Medbio platform, expanding the company’s geographic presence, while creating cross-selling opportunities across an attractive base of blue-chip medical device customers. The acquisition of PCI is also expected to present significant operational and commercial synergies as PCI joins Medbio.

Chris Williams, Medbio CEO, stated, “I’m looking forward to partnering with the PCI team to expand Medbio’s manufacturing capabilities, while reaching new customers and end markets.”